Legislation - SB0801

Repealing the requirement that each local correctional facility make available at least one formulation of each FDA-approved full opioid agonist, partial opioid agonist, and long-acting opioid antagonist used for the treatment of opioid use disorders; requiring the Maryland Secretary of Health to annually provide each county a grant equal to the costs incurred by the county for the implementation of a certain medication-assisted treatment program; and expanding the authorized uses of the Opioid Restitution Fund.

Committees

Original:: Budget and Taxation Click to view Recorded Media; Judicial Proceedings

Committee Testimony

Witness List

Details

Cross-filed with: HB1031

Bill File Type: Regular

Effective Date(s): October 1, 2024

History

Legislation History
Chamber Senate Calendar Date 2/02/2024 Legislative Date 2/02/2024 Action First Reading Budget and Taxation and Judicial Proceedings Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Correctional Services – Medication–Assisted Treatment Proceedings
Chamber Senate Calendar Date 2/06/2024 Legislative Date 2/06/2024 Action Hearing 2/21 at 1:00 p.m. (Budget and Taxation) Proceedings

Chamber	Calendar Date	Legislative Date	Action
Senate	2/02/2024	2/02/2024	First Reading Budget and Taxation and Judicial Proceedings
			Text - First - Correctional Services – Medication–Assisted Treatment
Senate	2/06/2024	2/06/2024	Hearing 2/21 at 1:00 p.m. (Budget and Taxation)

File Code

Subjects

Statutes